## WAT: Waters Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -2.8% below STRENGTH zone (3.0-6.0%); PEG 5.39 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($372.87)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Is Invesco Water Resources ETF (PHO) a Strong ETF Right Now?**
- Source: www.sharewise.com | 20251206T050055 | Somewhat-Bullish | Relevance: 64%
-  The Invesco Water Resources ETF (PHO) is a smart beta ETF that invests in companies focused on water conservation and purification. It has amassed over $2.15 billion in assets and aims to track the NASDAQ OMX US Water Index. The fund has an annual expense ratio of 0.59% and has shown a year-to-date return of 10.21% as of December 5, 2025.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $423 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | init | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 52.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.9% (+3.3%)
- Blackrock Inc.: 10.2% (-7.6%)
- Fundsmith LLP: 6.6% (+9.6%)
- Massachusetts Financ: 4.5% (+44.3%)
- State Street Corpora: 4.5% (+0.1%)

### Key Risks

1. Valuation stretched: PEG 5.4x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 5.39 signals overvaluation risk, limited margin of safety. Forward P/E 27.5x stretched relative to 9% growth. Quality metrics strong (ROE 33%, ROA 12%, margin 21%). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $23.4B |
| Beta | 1.16 |
| 52W Range | $275.05 - $423.56 |
| Short Interest | 5.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.39 |
| Forward P/E | 27.5 |
| Current P/E | 29.9 |
| YoY Growth | 9.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -1.4% to -2.8% (-1.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.8pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-2.11), momentum weakening. RSI neutral at 60.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.77% (CS: 25) | Weak |
| RSI_14 | 59.9 | Neutral |
| MACD Histogram | -2.11 | Bearish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.091x | Above |
| vs SMA200 | 1.159x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $392.75
- **Stop Loss:** $372.87 (5.1% risk)
- **Target:** $412.63 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 25
- **Position Value:** $9,818.75
- **Portfolio %:** 9.82%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-11 (Est: $4.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.22 | $3.40 | +5.5% |
| 2025Q2 | $2.94 | $2.95 | +0.3% |
| 2025Q1 | $2.22 | $2.25 | +1.2% |
| 2024Q4 | $4.03 | $4.10 | +1.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*